Affordable Access

deepdyve-link
Publisher Website

Reporting 'Denominator' data is essential for benchmarking and quality standards in ovarian cancer.

Authors
  • Phillips, Andrew1
  • Balega, Janos1
  • Nevin, James1
  • Singh, Kavita1
  • Elattar, Ahmed1
  • Kehoe, Sean2
  • Sundar, Sudha3
  • 1 Pan-Birmingham Gynaecological Cancer Centre, City Hospital, Dudley Rd, Birmingham B18 7QH, United Kingdom. , (United Kingdom)
  • 2 Pan-Birmingham Gynaecological Cancer Centre, City Hospital, Dudley Rd, Birmingham B18 7QH, United Kingdom; Institute of Cancer and Genomic Sciences, Vincent Drive, University of Birmingham, Birmingham B15 2TT, United Kingdom. , (United Kingdom)
  • 3 Pan-Birmingham Gynaecological Cancer Centre, City Hospital, Dudley Rd, Birmingham B18 7QH, United Kingdom; Institute of Cancer and Genomic Sciences, Vincent Drive, University of Birmingham, Birmingham B15 2TT, United Kingdom. Electronic address: [email protected] , (United Kingdom)
Type
Published Article
Journal
Gynecologic Oncology
Publisher
Elsevier
Publication Date
Jul 01, 2017
Volume
146
Issue
1
Pages
94–100
Identifiers
DOI: 10.1016/j.ygyno.2017.04.007
PMID: 28411948
Source
Medline
Keywords
License
Unknown

Abstract

Denominator data is critical to understanding selection and OS in AOC. Published outcomes of selected cohorts should routinely incorporate outcomes for all women managed within the reporting Centre. This is essential for benchmarking and quality assurance in gynaecological cancer and should be an integral part of any publication on outcomes from AOC.

Report this publication

Statistics

Seen <100 times